Modeling Native EHEC Outer Membrane Vesicles by Creating Synthetic Surrogates
暂无分享,去创建一个
[1] Yutaka Suzuki,et al. RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells , 2020, Scientific Reports.
[2] A. Mellmann,et al. Real- time interaction analysis of Shiga toxins and membrane microdomains of primary human brain microvascular endothelial cells. , 2019, Glycobiology.
[3] G. Wunderlich,et al. Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC) , 2018, Brazilian Journal of Microbiology.
[4] A. Mellmann,et al. Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB. , 2018, International journal of medical microbiology : IJMM.
[5] A. Mellmann,et al. Combining Mass Spectrometry, Surface Acoustic Wave Interaction Analysis, and Cell Viability Assays for Characterization of Shiga Toxin Subtypes of Pathogenic Escherichia coli Bacteria. , 2018, Analytical chemistry.
[6] H. Karch,et al. Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines , 2017, Toxins.
[7] S. Loos,et al. Haemolytic uraemic syndrome , 2017, Journal of internal medicine.
[8] A. Mellmann,et al. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury , 2017, PLoS pathogens.
[9] Hongwei Zhang,et al. Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation. , 2017, Methods in molecular biology.
[10] S. Antimisiaris. Preparation of DRV Liposomes. , 2017, Methods in molecular biology.
[11] B. Kemper,et al. Shiga toxin of enterohaemorrhagic Escherichia coli directly injures developing human erythrocytes , 2016, Cellular microbiology.
[12] M. Kuehn,et al. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions , 2015, Nature Reviews Microbiology.
[13] Björn Kemper,et al. Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain , 2015, Scientific Reports.
[14] A. Mellmann,et al. Enterohemorrhagic Escherichia coli Hemolysin Employs Outer Membrane Vesicles to Target Mitochondria and Cause Endothelial and Epithelial Apoptosis , 2013, PLoS pathogens.
[15] Hui Sun,et al. Enterohemorrhagic Escherichia coli Specific Enterohemolysin Induced IL-1β in Human Macrophages and EHEC-Induced IL-1β Required Activation of NLRP3 Inflammasome , 2012, PloS one.
[16] Mary K. Lewinski,et al. Renal and neurological involvement in typical Shiga toxin-associated HUS , 2012, Nature Reviews Nephrology.
[17] B. Kemper,et al. Facing glycosphingolipid–Shiga toxin interaction: dire straits for endothelial cells of the human vasculature , 2012, Cellular and Molecular Life Sciences.
[18] K. Sandvig,et al. Shiga toxins. , 2012, Toxicon : official journal of the International Society on Toxinology.
[19] Patrik Langehanenberg,et al. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells , 2010, Thrombosis and Haemostasis.
[20] A. Kane,et al. Shiga Toxin 2 and Flagellin from Shiga-Toxigenic Escherichia coli Superinduce Interleukin-8 through Synergistic Effects on Host Stress-Activated Protein Kinase Activation , 2010, Infection and Immunity.
[21] M. Kuehn,et al. Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles , 2010, Microbiology and Molecular Biology Reviews.
[22] L. Johannes,et al. Shiga toxins — from cell biology to biomedical applications , 2010, Nature Reviews Microbiology.
[23] L. Johannes,et al. Intracellular trafficking of Shiga‐toxin‐B‐subunit‐functionalized spherulites , 2008, Biology of the cell.
[24] B. Delord,et al. Specific adsorption of functionalized colloids at the surface of living cells: a quantitative kinetic analysis of the receptor-mediated binding. , 2008, Biochimica et biophysica acta.
[25] A. Mellmann,et al. Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.
[26] P. Bassereau,et al. Key role of receptor density in colloid/cell specific interaction: a quantitative biomimetic study on giant vesicles , 2008, The European physical journal. E, Soft matter.
[27] R. Polanowska-Grabowska,et al. Shiga Toxin 2 and Lipopolysaccharide Induce Human Microvascular Endothelial Cells To Release Chemokines and Factors That Stimulate Platelet Function , 2005, Infection and Immunity.
[28] H. Karch,et al. Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.
[29] P. Tarr,et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.
[30] Tana,et al. Induction of intestinal IgA and IgG antibodies preventing adhesion of verotoxin‐producing Escherichia coli to Caco‐2 cells by oral immunization with liposomes , 2003, Letters in applied microbiology.
[31] N. Nagata,et al. Protection of Monkeys against Shiga Toxin Induced by Shiga Toxin-Liposome Conjugates , 2002, International Archives of Allergy and Immunology.
[32] L. Barbieri,et al. Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells 1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] A. Friedrich,et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.
[34] S. Ichikawa,et al. Enzymes inside lipid vesicles: preparation, reactivity and applications. , 2001, Biomolecular engineering.
[35] K. Yokoyama,et al. Production of shiga toxin by Escherichia coli measured with reference to the membrane vesicle-associated toxins. , 2000, FEMS microbiology letters.
[36] Glynis L. Kolling,et al. Export of Virulence Genes and Shiga Toxin by Membrane Vesicles of Escherichia coli O157:H7 , 1999, Applied and Environmental Microbiology.
[37] N. Nagata,et al. Induction of Protection against Oral Infection with Cytotoxin–Producing Escherichia coli O157:H7 in Mice by Shiga–like Toxin–Liposome Conjugate , 1998, International Archives of Allergy and Immunology.
[38] T. Uchida,et al. Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxin. , 1997, International archives of allergy and immunology.
[39] R. Macdonald,et al. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. , 1991, Biochimica et biophysica acta.
[40] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[41] H. Lior,et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.
[42] J Konowalchuk,et al. Vero response to a cytotoxin of Escherichia coli , 1977, Infection and immunity.
[43] R. Peters,et al. Distribution of lipids in cytoplasmic and outer membranes of Escherichia coli K12. , 1976, Biochimica et biophysica acta.
[44] W. Lennarz,et al. Distribution of Lipids in the Wall and Cytoplasmic Membrane Subfractions of the Cell Envelope of Escherichia coli , 1972, Journal of bacteriology.